Atossa Therapeutics, Inc. (ATOS) vs Rein Therapeutics Inc. (RNTX)
A side-by-side comparison of Atossa Therapeutics, Inc. and Rein Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATOS
Atossa Therapeutics, Inc.
$2.48HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
RNTX
Rein Therapeutics Inc.
$0.82HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ATOS vs RNTX
growth of $100 · dividends reinvested · last 2yATOS -85.4% (-61.8%/yr)RNTX -61.1% (-37.6%/yr)RNTX compounded faster over this window
ATOS RNTX
ATOS vs RNTX: by the numbers
- •ATOS is the larger company ($25M vs $23M market cap).
Metrics side by side
Valuation
| Metric | ATOS | RNTX |
|---|---|---|
| P/B ratio | 0.92 | 2.25 |
Profitability
| Metric | ATOS | RNTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -140.55% | -487.90% |
| ROIC | -146.30% | -36.89% |
Growth (annualized)
| Metric | ATOS | RNTX |
|---|---|---|
| Total return CAGR (5Y) | -44.50% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.